Corbus Pharmaceuticals Holdings, Inc. Other Operating Income (Expense), Net
Corbus Pharmaceuticals Holdings, Inc. (CRBP) reported Other Operating Income (Expense), Net of $1.15 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OtherOperatingIncomeExpenseNet · last filed 2026-08-06
- Corbus Pharmaceuticals Holdings, Inc. other operating income (expense), net for the quarter ending 2026-06-30 was $1.15M, a 22.62% decline year-over-year.
- Corbus Pharmaceuticals Holdings, Inc. other operating income (expense), net for the quarter ending 2025-06-30 was $1.49M.
- Corbus Pharmaceuticals Holdings, Inc. other operating income (expense), net for the quarter ending 2024-09-30 was $0.00, a 100.00% decline year-over-year.
- Corbus Pharmaceuticals Holdings, Inc. other operating income (expense), net for the quarter ending 2024-06-30 was $0.00.
| Period end | Other Operating Income (Expense), Net 3 month | Other Operating Income (Expense), Net 6 month | Other Operating Income (Expense), Net 9 month |
|---|---|---|---|
| 2026-06-30 | $1.15M 10-Q · filed 2026-08-06 | $2.49M 10-Q · filed 2026-08-06 | |
| 2025-06-30 | $1.49M 10-Q · filed 2026-08-06 | $4.29M 10-Q · filed 2026-08-06 | |
| 2024-09-30 | $0.00 10-Q · filed 2024-11-07 | $0.00 derived: sum of 2 quarters · filed 2024-11-07 | $2.50M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $0.00 10-Q · filed 2024-08-06 | $2.50M 10-Q · filed 2024-08-06 | |
| 2024-03-31 | $2.54M 10-Q · filed 2024-05-07 | ||
| 2023-09-30 | $100.00K 10-Q · filed 2024-11-07 | $100.00K derived: sum of 2 quarters · filed 2024-11-07 | $100.00K 10-Q · filed 2024-11-07 |
| 2023-06-30 | $0.00 10-Q · filed 2024-08-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |